- Published on
Emergency and acute medicine – Chemical Weapons Poisoning
General overview
Chemical weapons poisoning refers to exposure to toxic agents designed to cause injury or death by affecting the central nervous system, lungs, cardiovascular system, skin, eyes, or gastrointestinal tract. These agents may be encountered in warfare, terrorism, industrial accidents, or mass casualty incidents and often involve multiple victims presenting simultaneously.
Types of agents and mechanisms
Blood agents such as cyanide disrupt cellular respiration by binding to cytochrome oxidase and uncoupling oxidative phosphorylation, leading to rapid tissue hypoxia.
Blister agents, including sulfur mustard, nitrogen mustard, lewisite, and phosgene oxime, cause alkylation and cross-linking of DNA and proteins, resulting in cellular membrane damage and delayed tissue necrosis.
Lacrimators and riot control agents, such as CN (Mace), CS, oleoresin capsaicin, chloropicrin, and adamsite, primarily irritate mucous membranes.
Pulmonary irritants, also known as choking agents, vary by water solubility. Highly soluble agents like ammonia mainly affect the upper airway, intermediate agents such as chlorine damage both upper and lower airways through free radical formation, and low-solubility agents like phosgene cause delayed pulmonary edema after hydrolysis in the lungs.
Nerve agents, including sarin, tabun, soman, and VX, inhibit acetylcholinesterase, resulting in widespread cholinergic overstimulation at muscarinic, nicotinic, and central nervous system receptors.
Incapacitating agents such as 3-quinuclidinyl benzilate (BZ) produce an anticholinergic toxidrome through antimuscarinic effects.
Clinical features
History often suggests exposure through reports of multiple affected individuals, fires, industrial incidents, or known chemical release.
Blood agents cause early tachypnea, hypertension, and tachycardia followed by respiratory depression, hypotension, bradycardia, seizures, coma, and rapid death. Cyanosis is uncommon, and metabolic acidosis is prominent.
Blister agents lead to delayed skin erythema, edema, pruritus, vesiculation, and necrosis, along with severe ocular injury, airway sloughing, bronchospasm, and bone marrow suppression.
Lacrimators cause intense eye pain, lacrimation, blepharospasm, temporary blindness, skin irritation, cough, and chest tightness.
Pulmonary irritants produce dyspnea, cough, bronchospasm, chest pain, and delayed pulmonary edema that may appear up to 24 hours after exposure.
Nerve agents produce the classic SLUDGEBAM syndrome with salivation, lacrimation, urination, defecation, gastrointestinal cramps, emesis, bronchorrhea, bronchoconstriction, bradycardia, miosis, seizures, muscle fasciculations, weakness, and paralysis.
Incapacitating agents result in anticholinergic findings including hyperthermia, dry skin, flushed appearance, delirium, tachycardia, urinary retention, and decreased bowel sounds.
Evaluation and recognition
Diagnosis is primarily clinical and based on exposure history and toxidrome recognition. Physical examination may reveal clues such as bitter almond odor and severe acidosis in cyanide poisoning, blistering and skin sloughing with mustard agents, or marked secretions and miosis with nerve agents.
Laboratory and imaging findings
Arterial blood gases may show severe metabolic acidosis and elevated lactate in cyanide exposure. Complete blood counts can reveal leukopenia, thrombocytopenia, or anemia after mustard exposure. Electrolytes, renal function, creatine phosphokinase, and urinalysis assist in monitoring systemic injury. Erythrocyte cholinesterase activity supports nerve agent exposure. Chest radiography is useful to assess pulmonary edema.
Differential considerations
Conditions that may mimic chemical weapons exposure include asthma or COPD exacerbations, Stevens–Johnson syndrome, toxic epidermal necrolysis, organophosphate pesticide poisoning, botulism, radiation injury, congestive heart failure, and anaphylactoid reactions.
Prehospital priorities
Prevent secondary contamination by using appropriate personal protective equipment. Immediate decontamination is critical, with removal of clothing and either dry or wet decontamination depending on the agent. Atropine should be administered early in suspected nerve agent exposure even if tachycardia is present.
Initial stabilization
Airway, breathing, and circulation take priority. Patients require rapid decontamination, copious irrigation of skin and eyes, supplemental oxygen, cardiac monitoring, pulse oximetry, and intravenous access with isotonic fluids. Health care workers must remain protected throughout care.
Emergency department management
Treatment focuses on decontamination, supportive care, and agent-specific antidotes. Cyanide exposure requires high-flow oxygen, seizure control, and hydroxocobalamin as first-line therapy, with traditional cyanide antidote kits as alternatives.
Blister agents are managed with supportive and burn care, fluid and electrolyte monitoring, and management of hematologic complications.
Pulmonary irritants and lacrimators are treated with supportive respiratory care, bronchodilators, eye irrigation, and observation for delayed pulmonary edema.
Nerve agent poisoning requires aggressive airway management, repeated high-dose atropine titrated to respiratory improvement, pralidoxime to reverse neuromuscular effects, and benzodiazepines for seizures.
Incapacitating agents are managed with supportive care, hydration, benzodiazepines for agitation, and consideration of physostigmine in consultation with a poison center.
Pharmacologic therapy
Key medications include atropine, pralidoxime, hydroxocobalamin, benzodiazepines, bronchodilators, and components of the cyanide antidote kit, dosed according to severity and patient age.
Disposition and monitoring
Patients with significant exposure or symptoms require hospital or intensive care admission for monitoring and supportive care. Those exposed to riot control agents alone may be observed in the emergency department and discharged if symptoms resolve.
Clinical pearls
Effective decontamination is essential to protect both patients and clinicians. Recognition of toxidromes allows early, life-saving antidote administration. Delayed complications, particularly pulmonary edema after choking agents, require vigilant observation even when initial symptoms are mild.
General overview
Chemical weapons poisoning refers to exposure to toxic agents designed to cause injury or death by affecting the central nervous system, lungs, cardiovascular system, skin, eyes, or gastrointestinal tract. These agents may be encountered in warfare, terrorism, industrial accidents, or mass casualty incidents and often involve multiple victims presenting simultaneously.
Types of agents and mechanisms
Blood agents such as cyanide disrupt cellular respiration by binding to cytochrome oxidase and uncoupling oxidative phosphorylation, leading to rapid tissue hypoxia.
Blister agents, including sulfur mustard, nitrogen mustard, lewisite, and phosgene oxime, cause alkylation and cross-linking of DNA and proteins, resulting in cellular membrane damage and delayed tissue necrosis.
Lacrimators and riot control agents, such as CN (Mace), CS, oleoresin capsaicin, chloropicrin, and adamsite, primarily irritate mucous membranes.
Pulmonary irritants, also known as choking agents, vary by water solubility. Highly soluble agents like ammonia mainly affect the upper airway, intermediate agents such as chlorine damage both upper and lower airways through free radical formation, and low-solubility agents like phosgene cause delayed pulmonary edema after hydrolysis in the lungs.
Nerve agents, including sarin, tabun, soman, and VX, inhibit acetylcholinesterase, resulting in widespread cholinergic overstimulation at muscarinic, nicotinic, and central nervous system receptors.
Incapacitating agents such as 3-quinuclidinyl benzilate (BZ) produce an anticholinergic toxidrome through antimuscarinic effects.
Clinical features
History often suggests exposure through reports of multiple affected individuals, fires, industrial incidents, or known chemical release.
Blood agents cause early tachypnea, hypertension, and tachycardia followed by respiratory depression, hypotension, bradycardia, seizures, coma, and rapid death. Cyanosis is uncommon, and metabolic acidosis is prominent.
Blister agents lead to delayed skin erythema, edema, pruritus, vesiculation, and necrosis, along with severe ocular injury, airway sloughing, bronchospasm, and bone marrow suppression.
Lacrimators cause intense eye pain, lacrimation, blepharospasm, temporary blindness, skin irritation, cough, and chest tightness.
Pulmonary irritants produce dyspnea, cough, bronchospasm, chest pain, and delayed pulmonary edema that may appear up to 24 hours after exposure.
Nerve agents produce the classic SLUDGEBAM syndrome with salivation, lacrimation, urination, defecation, gastrointestinal cramps, emesis, bronchorrhea, bronchoconstriction, bradycardia, miosis, seizures, muscle fasciculations, weakness, and paralysis.
Incapacitating agents result in anticholinergic findings including hyperthermia, dry skin, flushed appearance, delirium, tachycardia, urinary retention, and decreased bowel sounds.
Evaluation and recognition
Diagnosis is primarily clinical and based on exposure history and toxidrome recognition. Physical examination may reveal clues such as bitter almond odor and severe acidosis in cyanide poisoning, blistering and skin sloughing with mustard agents, or marked secretions and miosis with nerve agents.
Laboratory and imaging findings
Arterial blood gases may show severe metabolic acidosis and elevated lactate in cyanide exposure. Complete blood counts can reveal leukopenia, thrombocytopenia, or anemia after mustard exposure. Electrolytes, renal function, creatine phosphokinase, and urinalysis assist in monitoring systemic injury. Erythrocyte cholinesterase activity supports nerve agent exposure. Chest radiography is useful to assess pulmonary edema.
Differential considerations
Conditions that may mimic chemical weapons exposure include asthma or COPD exacerbations, Stevens–Johnson syndrome, toxic epidermal necrolysis, organophosphate pesticide poisoning, botulism, radiation injury, congestive heart failure, and anaphylactoid reactions.
Prehospital priorities
Prevent secondary contamination by using appropriate personal protective equipment. Immediate decontamination is critical, with removal of clothing and either dry or wet decontamination depending on the agent. Atropine should be administered early in suspected nerve agent exposure even if tachycardia is present.
Initial stabilization
Airway, breathing, and circulation take priority. Patients require rapid decontamination, copious irrigation of skin and eyes, supplemental oxygen, cardiac monitoring, pulse oximetry, and intravenous access with isotonic fluids. Health care workers must remain protected throughout care.
Emergency department management
Treatment focuses on decontamination, supportive care, and agent-specific antidotes. Cyanide exposure requires high-flow oxygen, seizure control, and hydroxocobalamin as first-line therapy, with traditional cyanide antidote kits as alternatives.
Blister agents are managed with supportive and burn care, fluid and electrolyte monitoring, and management of hematologic complications.
Pulmonary irritants and lacrimators are treated with supportive respiratory care, bronchodilators, eye irrigation, and observation for delayed pulmonary edema.
Nerve agent poisoning requires aggressive airway management, repeated high-dose atropine titrated to respiratory improvement, pralidoxime to reverse neuromuscular effects, and benzodiazepines for seizures.
Incapacitating agents are managed with supportive care, hydration, benzodiazepines for agitation, and consideration of physostigmine in consultation with a poison center.
Pharmacologic therapy
Key medications include atropine, pralidoxime, hydroxocobalamin, benzodiazepines, bronchodilators, and components of the cyanide antidote kit, dosed according to severity and patient age.
Disposition and monitoring
Patients with significant exposure or symptoms require hospital or intensive care admission for monitoring and supportive care. Those exposed to riot control agents alone may be observed in the emergency department and discharged if symptoms resolve.
Clinical pearls
Effective decontamination is essential to protect both patients and clinicians. Recognition of toxidromes allows early, life-saving antidote administration. Delayed complications, particularly pulmonary edema after choking agents, require vigilant observation even when initial symptoms are mild.
0 Comments
